ANTIBIOTIC RESISTANCE PATTERNS OF COMMON UROPATHOGENS ISOLATED FROM FEMALES AT ZAKHO CITY, KURDISTAN REGION, IRAQ.
DOI:
https://doi.org/10.25271/sjuoz.2024.12.4.1395Keywords:
antibiotic sensitivity, antibiotic resistance, bacteria, infectious disease, urinary tract infection, uropathogensAbstract
Background: Urinary tract infection (UTI) is an infection in any part of the urinary system, including kidneys, ureters, bladder, and urethra. Uropathogenic bacterial-antibiotic resistance has become a severe challenge among UTI-causative agents. Objective: This work attempted to screen the activity of a wide range of antibiotics routinely used for UTI-derived infection management to assess the impact of antibiotics on some common UTI pathogens isolated from females. Method: This retrospective study was performed at Zakho Emergency Hospital, Kurdistan region of Iraq, from January 2016 to December 2019. Conventional bacteriological tests were used to identify the most common isolated uropathogens in females. The antibiotic sensitivity test was performed according to the Clinical and Laboratory Standards Institute (CLSI). The bacterial-antibiotics assay was determined using the disk diffusion (Kirby-Bauer) method, which depended on the microbiology laboratory records. Results: Out of 1730 urine samples, 1040 (60.4%) were found to be pathogens-positive samples. The most common uropathogens isolated were Staphylococcus spp 44% (n=460), Escherichia coli strains 25.35% (n=265), Klebsiella spp 15.78% (n=65), and Streptococcus spp 14.83 (n=155). Regarding the microbial-antibiotic resistance, ≤ 25% of the UTI investigated cases, except Streptococcus spp, meropenem, imipenem, and amikacin, showed a remarkable effect against all addressed pathogens. Vancomycin was the first choice against gram-positive bacteria in addition to rifampicin and doxycycline for Streptococcus spp. Gentamycin was found to be the most effective antimicrobial against Klebsiella spp. Concerning bacterial-antibiotic resistance ≥75% and excluding Streptococcus spp, amoxicillin, ampicillin/cloxacillin, erythromycin, clindamycin, cloxacillin, and metronidazole were completely non-functional against all bacteria. Azithromycin, norfloxacin, oxacillin, cefixime, nalidixic acid, and ceftazidime showed relatively weak activity against gram-positive bacteria in addition to cephalexin, ceftriaxone, and cloxacillin for Streptococcus spp. Ampicillin, augmentin, penicillin, and cephalexin were comparatively non-functional against gram-negative pathogens in addition to vancomycin, rifampicin, cephalothin, oxacillin, and trimethoprim for Klebsiella spp. All remaining antibiotics produced an activity ranging between ≥25% to ≤75% of examined cases. The results of this work may help clinicians to accurate their antibiotic-bacterial infection empirical treatment. Conclusion: All subjected bacteria exhibited a strong resistance to a broad spectrum of antibiotics. Therefore, except for imipenem, meropenem, or amikacin, an antibiotic sensitivity test should be conducted prior to prescribing any antibiotic.
References
Abalkhail A., and Alslamah T., (2022). Institutional factors associated with infection prevention and control practices globally during the infectious pandemic in resource-limited settings. Vaccines, 10(11): 1811. DOI: http://10.3390/vaccines10111811.
Abdulrahman M., and Taher A., (2018). Prevalence of methicillin-resistant Staphylococcus aureus among food handlers in Duhok City. Science Journal of University of Zakho, 6(4): 140-145. DOI: https://doi.org/10.25271/sjuoz.2018.6.4.540.
Abduljabar S., and Naqid I., (2022). Staphylococcus aureus among athletes in Zakho City, Kurdistan Region, Iraq: Nasal carriage rate, risk factors, and antibiotic sensitivity profile. Science Journal of University of Zakho, 10(3), DOI: https://doi.org/10.25271/sjuoz.2022.10.3.929.
Alhamadani Y., and Oudah A., (2022). Study of the bacterial sensitivity to different antibiotics, which are isolated from patients with UTI, using the Kirby-Bauer Method. Journal of Biomedicine and Biochemistry, 1(2): 1-5. DOI: http://10.57238/jbb.2022.19387.
Alhazmi A., Alameer K., Abuageelah B., Alharbi R., et al., (2023). Epidemiology and antimicrobial resistance patterns of urinary tract infections: A cross-sectional study from Southwestern Saudi Arabia. Medicina, 59: 1411. DOI: https://doi.org/10.3390/medicina59081411.
Ali A., Sayed N., and Hassan R., (2022). Study of vancomycin susceptibility pattern among Staphylococcus aureus isolated from superficial incisional surgical site infections. Microbes and Infectious Diseases, 3(2): 309-317. DOI: http://10.21608/mid.2022.115351.1232.
Assafi M., and Ali F., (2022). An epidemiological and multidrug resistance study for E. coli isolated from urinary tract infection (three years of study). Baghdad Science Journal, 19(1): 7-15. DOI: http://orcid.org/0000-0003-1005-3694.
Borek A., Edwards G., Santillo M., Wanat M., et al., (2023). Re-examining advice to complete antibiotic courses: a qualitative study with clinicians and patients. British Journal of General Practice, 7(2): DOI: 10.3399/BJGPO.2022.0170.
Chiorescu R., Buksa S., Botan A., et al., (2024). Vancomycin-resistant Streptococcus thoraltensis: A case report of bacterial endocarditis and review of literature on infections caused by this pathogen. Microorganisms, 12;12(3):566. https://doi.org/10.3390/microorganisms12030566.
CLSI, (2020). Performance standards for antimicrobial susceptibility testing, 30th Ed. Vol 40. Wayne, PA: Clinical and Laboratory Standards Institute. ISBN 978-1-68440-067-6 (Electronic).
Coque T., Cantón R., Pérez-Cobas A., Fernández M., (2023). Antimicrobial resistance in the global health network: Known unknowns and challenges for efficient responses in the 21st century. Microorganisms, 11(4), 1050. DOI: https://doi.org/10.3390/microorganisms/11041050.
Eliakim-Raz N., Babitch T., Shaw E., Addy I., Wiegand I. et al., (2019). Risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: A Multicenter retrospective cohort study. Clinical Infectious Diseases, 68(1): 29–36. https://doi.org/10.1093/cid/ciy418.
Esfahani S., Rostami S., and Poorshariat S., (2024). Antimicrobial susceptibility patterns of Escherichia coli isolates from hospitalized patients with different infections in Isfahan, Iran: Impact on empiric antibiotic therapy in associated infections. International Journal of Infection, 10(2): https://doi.org/10.5812/iji-141058.
Flores-Mireles A., Walker J., Caparon M., and Hultgren S., (2015). Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nature Reviews Microbiology, 3:269–284. DOI: http://10.1038/nrmicro3432.
Gaurav A., Bakht P., Saini M., Pandey S., and Pathania R., (2023). Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology, 69(5):001333. DOI: http://10.1099/mic.0.001333.
Ghazala Muteeb G., Rehman T., Shahwan M., and Aatif M., (2023). Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review. Pharmaceuticals, 16(11), 1615. DOI: https://doi.org/10.3390/ph16111615.
Giuliano C., Patel R., and Kale-Pradhan P., (2019). A guide to bacterial culture identification and results interpretation. Pharmacy and therapeutic, 44(4):192-200. ID: PMID30930604.
Guclu E., Halis F., Kose E., Ogutlu A., and Karabay O., (2021). Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections. African Health Sciences, 21(1): 214-219. DOI: http://10.4314/ahs.v21i1.28.
Li Y., Kumar S., Zhang L., Wu H., and Wu H., (2023). Characteristics of antibiotic resistance mechanisms and genes of Klebsiella pneumoniae. Open Medicine, 18(1): 20230707. DOI: http://10.1515/med-2023-0707.
Luo H., Xu L., and Chen Y., (2023). Drug resistance and susceptibility of amikacin in children with extended-spectrum beta-lactamase-producing Enterobacterales: a systematic review with meta-analysis. Diagnostic Microbiology and Infectious Disease, 106(4): 115956. DOI: http://10.1016/j.diagmicrobio.2023.115956.
Maher C., and Hassan K., (2023). The Gram-negative permeability barrier: tipping the balance of the in and the out. AMS Journals, mBio14: e01205-23. DOI: https://doi.org/10.1128/mbio.01205-23.
Mares C., Petca R., Popescu R., Petca A., Multescu R., et al., (2024). Update on urinary tract infection antibiotic resistance - A retrospective study in females in conjunction with clinical data. Life, 14, 106. DOI: https://doi.org/10.3390/life14010106.
Mhawesh A., Khudair M., Radeef Y., Chillab R., and Jaber M., (2021). Antibiotic susceptibility patterns, and biofilm Formation for Klebsiella pneumoniae and Pseudomonas aeruginosa bacteria, its genotype identification and phenotype affiliation. International Journal of Drug Delivery Technology, 11(1):13-20. DOI: http://10.25258/ijddt.11.1.3.
Michaelis C., and Grohmann E., (2023). Horizontal gene transfer of antibiotic resistance genes in biofilms. Antibiotics, 12(2): 328. DOI: http://10.3390/antibiotics12020328.
Mohamed A., (2023). Antimicrobial Resistance Rates in Gram-positive Uropathogens in Duhok city, Kurdistan Region of Iraq. MedRvix, https://doi.org/10.1101/2023.02.26.23286459.
Nagaraj C., (2023). Hospital-acquired urinary tract infections. Advances and challenges in urine laboratory analysis. IntechOpen. DOI: http://10.5772/intechopen.110532.
Nandhini P., Kumar P., Mickymaray S., Alothaim A., et al., (2022). Recent developments in methicillin-resistant Staphylococcus aureus (MRSA) treatment: A review, antibiotics (Basel), 29;11(5):606. DOI: http://10.3390/antibiotics11050606.
Naqid I., Balatay A., Hussein N., Saeed K., Ahmed H., and Yousif S., (2020a). Antibiotic susceptibility pattern of Escherichia coli isolated from various clinical samples in Duhok City, Kurdistan Region of Iraq. International Journal of Infection, 7(3): https://doi.org/10.5812/iji.103740.
Naqid I., Hussein N., Balatay A., Saeed K., and Ahmed H., (2020b). The antimicrobial resistance pattern of Klebsiella pneumonia isolated from the clinical specimens in Duhok City in Kurdistan Region of Iraq. Journal of Kermanshah University of Medical Sciences, 24 (2). DOI: https://doi.org/10.5812/jkums.106135.
Nickel J., (2007). Urinary tract infections and resistant bacteria: Highlights of a symposium at the combined meeting of the 25th international congress of chemotherapy (ICC) and the 17th European congress of clinical microbiology and infectious diseases (ECCMID). Reviews in Urology, 9:78 80. PMCID: PMC1892623, PMID: 17592541.
Nyirjesy P., Brookhart C., Lazenby G., Schwebke J., and Sobel J., (2022). Vulvovaginal Candidiasis: A review of the evidence for the 2021 centers for disease control and prevention of sexually transmitted infections treatment guidelines. Clinical Infectious Diseases, 74(15): S162–S168. DOI: http://10.1093/cid/ciab1057.
Pathak A., Angst D., León-Sampedro R., and Hall A., (2023). Antibiotic-degrading resistance changes bacterial community structure via species-specific responses. ISME J, 17: 1495–1503. https://doi.org/10.1038/s41396-023-01465-2.
Qurbani K., Ali S., Hussein S., and Hamzah H., (2024). Antibiotic resistance in Kurdistan, Iraq: A growing concern. New Microbes and New Infections, 57: 1012-1021. DOI: http://10.1016/j.nmni.2024.101221.
Sabih A., and Leslie S., (2023). Complicated urinary tract infections. In: StatPearls, Treasure Island (FL): StatPearls Publishing; 2024. NCB Bookshelf ID: NBK436013. https://pubmed.ncbi.nlm.nih.gov/28613784/.
Seid M., Markos M., Aklilu A., Manilal A., Zakir A., et al., (2023). Community-acquired urinary tract infection among sexually active women: Risk factors, bacterial profile and their antimicrobial susceptibility patterns, Arba Minch, Southern Ethiopia. Infection and Drug Resistance, 18(16): 2297-2310. DOI: HTTP://10.2147/IDR.S407092.
Sharma S., Mohler J., Mahajan S., Schwartz S., et al., (2023). Microbial biofilm: A review on formation, infection, antibiotic resistance, control measures, and innovative treatment. Microorganisms, 11(6), 1614. DOI: https://doi.org/10.3390/microorganisms11061614.
Simone Marini S., Boucher C., Noyes N., and Prosperi M., (2023). The K-mer antibiotic resistance gene variant analyzer (KARGVA). Frontiers in Microbiology, 14: DOI: https://doi.org/10.3389/fmicb.2023.1060891.
Tiseo K., Huber L., Gilbert M., Robinson T., and Van Boeckel T., (2020). Global trends in antimicrobial use in food animals from 2017 to 2030. Antibiotics, 9: 918. DOI: http://10.3390/antibiotics9120918.
Ullah K., Baloch M., Saleem F., Khan A., Saeed H., and Islam M., (2022). Antibiotic susceptibility patterns of bacterial isolates of patients with upper respiratory tract infections. Brazilian Journal of Pharmaceutical Sciences, 58: e20484. DOI: https://doi.org/10.1590/s2175-97902022e20484.
Van N., Hai L., Luong V., Vinh N., Hoa P., Hung L., Son N., et al., (2024). Antimicrobial resistance patterns of Staphylococcus aureus isolated at a general hospital in Vietnam between 2014 and 2021. Infection and Drug Resistance, 17 259–273. DOI: http://10.2147/IDR.S437920.
Varela M., Stephen J., Lekshmi M., Ojha M., Wenzel N., Sanford L., Hernandez A., et al., (2021). Bacterial resistance to antimicrobial agents. Antibiotics, 10; 593. DOI: http://10.3390/antibiotics10050593.
WHO and ECDC report: Available online: https://www.ecdc.europa.eu/en/news-events/who-and-ecdc-report-antimicrobial-resistance-remains-healththreat-europe (accessed: 05 June 2023).
Wiedemann B., Heisig A., and Heisig P., (2014). Uncomplicated urinary tract infections and antibiotic resistance-epidemiological and mechanistic aspects. Antibiotics, 3: 341–352. DOI: http://10.3390/antibiotics3030341.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Fawzi Adil ISSA
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work, with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online.
